Cumberland Pharmaceuticals
CPIX
45 hedge funds and large institutions have $34.2M invested in Cumberland Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 3 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
9% more capital invested
Capital invested by funds: $31.4M → $34.2M (+$2.82M)
0% more funds holding
Funds holding: 45 → 45 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$351K |
| 2 |
Renaissance Technologies
New York
|
+$189K |
| 3 |
PM
Platinum Management
New York
|
+$127K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$63.2K |
| 5 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
+$50.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$2.68M |
| 2 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
-$513K |
| 3 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$426K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$300K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$84.4K |
CPIX Hedge Fund Activity: Q4 2014 in Review
45 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2014, worth a combined $34.2M — up 9% from $31.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CPIX positions and 3 closed out — a net gain of 2 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Millennium Management, adding an estimated $351K. The largest seller was Ariel Investments, cutting an estimated $2.68M.
- 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $34.2M of Cumberland Pharmaceuticals stock for Q4 2014, up 9% quarter-over-quarter.
- 5 funds opened new Cumberland Pharmaceuticals positions in Q4 2014 and 3 closed out, a net change of +2 holders.
- The largest Cumberland Pharmaceuticals buyer in Q4 2014 was Millennium Management, an estimated $351K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2014 was Ariel Investments, an estimated $2.68M sold.
Based on aggregated 13F filings for Q4 2014.